Smoking history and epidermal growth factor receptor expression as predictors of survival benefit from erlotinib for patients with non-small-cell lung cancer in the National Cancer Institute of Canada Clinical Trials Group study BR.21.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples